20 June 2013
Keywords: Pfizer, Lpath, AMD, Ophthalic disorders, iSONEP, ASONEP, Phylogica, Peptide based vaccines
Article | 21 December 2010
US drug behemoth Pfizer (NYSE: PFE) - which just a couple of weeks ago dumped its chief executive Jeff Kindler ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 December 2010
19 June 2013
© 2013 thepharmaletter.com